Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Adrenal Gland Disorders

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...

Cushing Syndrome I: Introduction

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...

Cushing Syndrome II: Pathophysiology

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...

Glucose Transporters

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Persistently increased frequency of diabetic ketoacidosis in new-onset type 1 diabetes in Polish children: nationwide analysis 2019-2022.

Frontiers in endocrinology·2026

Same author

Whole goat milk versus cow milk formula and atopic dermatitis in infants: A randomized clinical trial.

Clinical nutrition (Edinburgh, Scotland)·2026

Same author

Evaluated Childhood Obesity Prevention and Management Programs in Europe, 2015-2024: A Structured Narrative Review of Behavioral and Anthropometric Outcomes.

Nutrients·2026

Same author

Long-term body composition changes after bariatric surgery and their association with fat- and bone-derived hormones.

Endocrine·2026

Same author

Anthropometric and Body Composition Correlates of Hypertension in Children and Adolescents with Intellectual Disabilities.

Journal of clinical medicine·2026

Same author

Search for the most precise diagnosis of monogenic diabetes - the usefulness of short-read NGS method in molecular testing in Polish patients.

Acta diabetologica·2026

Search research articles

Related Experiment Video

Updated: Jul 11, 2026

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

Published on: April 25, 2016

[Familial glucocorticoid deficiency].

Artur Mazur¹, Mariusz Ostański, Maria Kalina

¹Instytut Fizjoterapii Uniwersytetu Rzeszowskiego. drmazur@poczta.onet.pl

Pediatric Endocrinology, Diabetes, and Metabolism

|September 21, 2007

Summary

Familial glucocorticoid deficiency (FGD) is a rare genetic disorder causing low cortisol. Treatment involves glucocorticoid replacement therapy, which helps prevent hypoglycemia and supports normal growth.

Area of Science:

Endocrinology
Genetics
Pediatrics

Context:

Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disorder.
Characterized by elevated ACTH and low morning cortisol unresponsive to ACTH stimulation.
Mineralocorticoid function is typically unaffected.

Purpose:

To describe the genetic basis, clinical presentation, and management of Familial Glucocorticoid Deficiency.
To differentiate FGD from Allgrove's syndrome.
To outline treatment strategies for glucocorticoid deficiency.

Summary:

FGD results from mutations in the ACTH receptor gene or regulatory regions, affecting adrenal cortex differentiation.
Clinical manifestations include failure to thrive, hypoglycemia, and skin hyperpigmentation, appearing in infancy or early childhood.

Related Experiment Videos

Last Updated: Jul 11, 2026

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

Published on: April 25, 2016

Allgrove's syndrome is a distinct condition with glucocorticoid deficiency plus alacrimia, achalasia, and neurological deficits.

Impact:

Early diagnosis and glucocorticoid replacement therapy are crucial for preventing life-threatening hypoglycemia.
Appropriate treatment ensures normal growth and development in affected children.
Understanding the genetic underpinnings aids in accurate diagnosis and genetic counseling.